Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Smoldering Multiple Myeloma × Simvastatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Polycystic Ovary Syndrome 5 Multiple Myeloma 5 Prostatic Neoplasms 4 Neoplasm Metastasis 3 Colorectal Neoplasms 3 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Pancreatic Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Breast Carcinoma In Situ 2 Wilms Tumor 1 Venous Thromboembolism 1 Urinary Bladder Neoplasms 1 Tuberous Sclerosis 1 Triple Negative Breast Neoplasms 1 Thrombosis 1 Smoldering Multiple Myeloma 1 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Retinoblastoma 1 Rectal Neoplasms 1 Perioperative Inflammatory Response 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neurotoxicity Syndromes 1 Neuroblastoma 1

Interventions

Lenalidomide 12 Dexamethasone 12 Calcium Dobesilate 6 carfilzomib 4 Melphalan 3 Curcumin 3 dexamethasone acetate 2 dexamethasone 21-phosphate 2 daratumumab 2 auricularum 2 Leflunomide 2 Denosumab 2 Cyclophosphamide 2 Bortezomib 2 selinexor 1 pomalidomide 1 poly ICLC 1 piperine 1 pembrolizumab 1 ixazomib 1 isatuximab 1 ibrutinib 1 iberdomide 1 fludarabine phosphate 1 fludarabine 1 elotuzumab 1 citarinostat 1 atezolizumab 1 Urination 1 Transplantation, Autologous 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00503763 2015-04-16

PSMMSS

Meir Medical Center

Phase 2 Withdrawn

Smoldering Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡